Clinical Trial

An Exploratory Clinical Trial of VGN-R08b in Patients With Type II Gaucher Disease

Name: An Exploratory Clinical Trial of VGN-R08b in Patients With Type II Gaucher Disease — clinical trial record (NCT06272149)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Early Phase 1

View on ClinicalTrials.gov →

Record status

This record was last updated February 22, 2024 (before its estimated January 15, 2025 completion). Its status may not reflect the trial's current state.

Summary

This exploratory trial is to prove the tolerability and safety of VGN-R08b to treat infants with type II Gaucher disease.

Trial Details

NCT Number	NCT06272149
Lead Sponsor	Xinhua Hospital, Shanghai Jiao Tong University School of Medicine Collaborators: Shanghai Vitalgen BioPharma Co., Ltd.
Conditions	Type II Gaucher Disease
Enrollment	6 participants
Start Date	2023-03-01
Primary Completion	2025-01-15 (estimated)
Study Completion	2029-02-28 (estimated)
Updated on ClinicalTrials.gov	2024-02-22